Related Experiment Video
Updated: Jun 25, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Translating proof-of-concept for platelet slip into improved antithrombotic therapeutic regimens
Scott J Denardo1, Pavlos P Vlachos2, Brett A Meyers2
1Medicine/Cardiology, Duke University Medical Center, Durham, NC, USA.
Platelet slip, a phenomenon where platelets glide along surfaces without direct contact, can reduce clot formation. Understanding this mechanism could personalize antithrombotic treatments for conditions like percutaneous coronary intervention.
Area of Science:
- Interdisciplinary research at the intersection of biological and physical sciences.
- Focus on platelet function and rheology in thrombosis.
Background:
- Platelets are critical in thrombosis, the formation of blood clots.
- Existing research demonstrates shear rate-dependent platelet slip at vascular stenosis and device surfaces.
- Platelet slip represents a functional gliding mechanism without direct contact, reducing coagulation cascade engagement.
Purpose of the Study:
- To translate the proof-of-concept of platelet slip into improved antithrombotic regimens.
- To review supporting basic and clinical research for platelet slip.
- To hypothesize variables affecting platelet slip and apply a construct model to challenge contemporary guidelines, especially for percutaneous coronary intervention (PCI).
Main Methods:
- Review of current biological and clinical research on platelet slip.
- Hypothesizing key variables influencing platelet slip.
- Application of a construct model to evaluate and challenge existing antithrombotic guidelines for various shear environments.
- Identification of future research directions in basic and clinical science.
Main Results:
- Proof-of-concept for shear rate-dependent platelet slip is established.
- Platelet slip diminishes platelet engagement with the coagulation cascade at interfaces.
- The study proposes a framework to challenge and refine current antithrombotic strategies.
Conclusions:
- Understanding and controlling platelet slip could lead to a paradigm shift in antithrombotic regimen selection based on predicted shear rate.
- This paradigm shift promises improved clinical outcomes and reduced complications, particularly for high-risk PCI.
- Potential for significant cost savings in healthcare is anticipated with optimized antithrombotic therapies.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis

